mechanism of action ipamorelin Peptide Therapy Ipamorelin | C38H49N9O5 | CID

Zinc transporter LIV1: a promising cell surface target for triple negative breast cancer

Research-grade quality with purity testing

One month is enough time to ensure the inflammation of the previous treatment has resolved

Kim, E.Y., Battaile, J.T., Patel, A.C., You, Y., Agapov, E., Grayson, M.H., Benoit, L.A., Byers, D.E

It appeared as the first in-line synthetic peptide that specifically triggered growth hormone release in a dose-dependent manner, both in cell cultures and in living organisms

Rarely, side effects may include headache, dizziness, thirst, pain at the injection site, and allergic reactions, so it is always recommended to perform the sessions under medical supervision